NCT02042170View on ClinicalTrials.gov

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Establishing Dose of Sr-hGH in ISS Patients

Interventions

DRUG

human growth hormone self-injection

Trial Locations (1)

Unknown

Ho Sung Kim, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY